Standard Biotools (LAB) EPS (Weighted Average and Diluted) (2019 - 2026)
Standard Biotools (LAB) reported EPS (Weighted Average and Diluted) of $0.33 for Q1 2026, up 650.0% year-over-year from $0.04 in Q1 2025, and up 725.0% on a QoQ basis from $0.04 in Q4 2025.
Standard Biotools (LAB) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.33 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 650.0% year-over-year to $0.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.2 (up 233.33% YoY) and the FY2025 annual result came in at -$0.15, up 61.54% from the prior year.
- EPS (Weighted Average and Diluted) grew to $0.33 in Q1 2026 per LAB's latest filing, from $0.04 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.33 in Q1 2026 and bottomed at -$0.99 in Q1 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.21 (2023), against an average of -$0.21.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) plunged 296.0%; it then surged 650.0% in 2026.
- Tracing LAB's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then jumped by 120.0% to $0.05 in 2024, then declined by 20.0% to $0.04 in 2025, then surged by 725.0% to $0.33 in 2026.
- Per Business Quant, the three latest LAB EPS (Weighted Average and Diluted) figures stand at $0.33 (Q1 2026), $0.04 (Q4 2025), and -$0.08 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | -0.07 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.22 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.99 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | -0.23 |
| Mar 31, 2021 | -0.25 |
| Dec 31, 2020 | -0.25 |
| Sep 30, 2020 | -0.08 |
| Jun 30, 2020 | -0.18 |
| Dec 31, 2019 | -0.19 |